Schor Chen

President & CEO, DirectorAdicet Bio, Inc. (ACET) · full profile →Form 4 · filed Oct 2, 2023
Net Selling
Open-Market Buys
$15K
Open-Market Sells
$15K
Net Open-Market Flow
-$165
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 2, 2023Tax withholding(F)23K$1.37$32K154K
Oct 2, 2023Buy(P)6K$1.33$7K43K
Sep 29, 2023Sell(S)6K$1.36$7K177K
Sep 28, 2023Sell(S)6K$1.42$8K38K
Sep 28, 2023Buy(P)6K$1.42$8K182K

Transaction Codes

F
Shares withheld for taxes
P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-051259) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ACET insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-23-051259"
Ask your agent
Use Arkolith to summarize insider buying and selling at Adicet Bio, Inc.
over the last 90 days and cite the filings.